Category: News

PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells

Cancer stem cells (CSC) have been implicated in disease recurrence, metastasis and therapeutic resistance, but effective targeting strategies for these cells are still wanting. VS-5584 is a potent and selective dual inhibitor of mTORC1/2 and Class I PI...

VS-5584 Preferentially Targets Cancer Stem Cells

Cancer stem cells (CSC) have been implicated in disease recurrence, metastasis, and therapeutic resistance, but effective targeting strategies for these cells are still wanting. VS-5584 is a potent and selective dual inhibitor of mTORC1/2 and class I ...

Activin upregulation by NF-{kappa}B is required to maintain mesenchymal features of cancer stem-like cells in non-small cell lung cancer

Soluble growth factors and cytokines within the tumor microenvironment aid in the induction of the epithelial-to-mesenchymal transition (EMT). Although EMT promotes the development of cancer-initiating cells (CICs), cellular mechanisms by which cancer ...

Activin Maintains Cancer-Initiating Cell Phenotypes

Soluble growth factors and cytokines within the tumor microenvironment aid in the induction of the epithelial-to-mesenchymal transition (EMT). Although EMT promotes the development of cancer-initiating cells (CIC), cellular mechanisms by which cancer ...

FGF Signaling in Imatinib-Resistant GIST

Kinase inhibitors such as imatinib have dramatically improved outcomes for patients with gastrointestinal stromal tumor (GIST), but many patients develop resistance to these treatments. Although in some patients this event corresponds with mutations i...